花园生物(300401) - 2016 Q1 - 季度财报

Financial Performance - Total operating revenue for Q1 2016 was ¥61,178,119.72, representing a 77.92% increase compared to ¥34,384,383.51 in the same period last year[8]. - Net profit attributable to shareholders decreased by 36.77% to ¥4,216,444.98 from ¥6,668,921.98 year-on-year[8]. - Net profit excluding non-recurring items fell by 49.44% to ¥2,725,285.45 from ¥5,390,079.32 in the previous year[8]. - Basic and diluted earnings per share decreased by 50.00% to ¥0.02 from ¥0.04 year-on-year[8]. - The net profit for Q1 2016 was RMB 4,216,444.98, down 36.77% from RMB 6,668,921.98 in the previous year, primarily due to lower average selling prices and gross margins of VD3 products[17]. - The total profit decreased by 37.88% to RMB 4,838,009.79, influenced by lower average selling prices and gross margins of VD3 products[17]. - The company reported a significant reduction in accounts payable from CNY 59,353,626.81 to CNY 41,610,414.27, a decrease of about 29.9%[40]. - The total profit for Q1 2016 was CNY 4,838,009.79, a decrease of 37.5% from CNY 7,787,889.60 in the same quarter last year[47]. Cash Flow - Net cash flow from operating activities was negative at -¥9,007,096.50, a decline of 181.26% compared to ¥11,083,962.25 in the same period last year[8]. - Cash received from sales and services increased by 42.62% to CNY 53,024,349.25, driven by higher sales revenue[18]. - Operating cash inflow increased by 37.83% to CNY 60,255,618.39, reflecting increased sales revenue[18]. - The net cash flow from operating activities turned negative at CNY -9,007,096.50, a decrease of 181.26% compared to the previous period[18]. - Cash flow from investment activities showed a net outflow of CNY -11,118,450.85, improving by 51.72% year-on-year[18]. - The ending balance of cash and cash equivalents was 49,308,778.00 CNY, down from 54,130,251.20 CNY, a decrease of 8.5%[55]. Assets and Liabilities - Total assets at the end of the reporting period were ¥793,402,162.24, a slight increase of 0.71% from ¥787,837,573.71 at the end of the previous year[8]. - Total liabilities rose to CNY 79,881,785.38 from CNY 75,812,642.72, marking an increase of about 4%[40]. - Current assets totaled CNY 308,619,419.04, up from CNY 297,774,881.13 at the start of the period, indicating a growth of approximately 4.5%[38]. - The company's equity attributable to shareholders reached CNY 713,520,376.86, slightly up from CNY 712,024,930.99[41]. Operational Risks - The company is facing management risks due to rapid expansion, which may impact operational capabilities if not managed properly[10]. - Fixed asset investment is increasing rapidly, with potential risks of rising costs and declining profits if production capacity is not effectively utilized[10]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,294, with the largest shareholder holding 37.91% of the shares[12]. - A cash dividend of CNY 0.15 per share was distributed to shareholders, totaling CNY 2,721 million based on a total share capital of 18,140 million shares[32]. - The company has complied with its cash dividend policy, ensuring clarity and protection of minority shareholders' rights[32]. Future Plans and Commitments - The company aims to enhance its market share and profitability by expanding existing business operations[24]. - The company plans to issue up to 50 million shares to raise a maximum of CNY 46,000 million for various projects, including CNY 13,400 million for core premix materials[30]. - The company has committed to ensuring that the cash distributed as dividends will not be less than 30% of the distributable profits if the diluted earnings per share fall below the previous year's level[24].